Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat.
D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000096:biosynthesis*; D002396:Catechols / Q000494:pharmacology; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D005640:Follicle Stimulating Hormone / Q000097:blood* / Q000378:metabolism; D007031:Hypothalamus / Q000032:analysis; D007986:Luteinizing Hormone / Q000097:blood* / Q000378:metabolism; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology*; D009638:Norepinephrine / Q000032:analysis / Q000096:biosynthesis; D010293:Pargyline / Q000494:pharmacology; D011388:Prolactin / Q000097:blood* / Q000378:metabolism; D011863:Radioimmunoassay; D051381:Rats; D012694:Serine / Q000494:pharmacology; D012701:Serotonin / Q000096:biosynthesis; D013859:Thiocarbamates / Q000494:pharmacology
D000596:Amino Acids; D002395:Catecholamines; D002396:Catechols; D008781:Methyltyrosines; D013859:Thiocarbamates; D012701:Serotonin; D012694:Serine; D004295:Dihydroxyphenylalanine; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D010293:Pargyline; D010134:Fenclonine; D009638:Norepinephrine